MedPath

Penetration-enhanced Direct DBD Non-thermal Plasma for Hair Loss

Not Applicable
Completed
Conditions
Androgenetic Alopecia
Registration Number
NCT06149221
Lead Sponsor
Dr. Peter C. Friedman
Brief Summary

In-office applied non-thermal atmospheric pressure plasma treatment on NS pretreated scalp

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
19
Inclusion Criteria
  • diagnosis of mild-to moderate androgenetic alopecia
  • ability to keep in-person follow-up appointments
Exclusion Criteria
  • any inflammatory scalp condition
  • starting or discontinuing any hair loss treatments within 6 months of start date
  • allergy to any components of the carrier solution

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Presence of detectable hair growth3 months and 6 months

Presence of hair growth as measured using the HairMetrix device

Secondary Outcome Measures
NameTimeMethod
Adverse effects related to the treatmentthroughout study completeion, 6 months

Patients are monitored for adverse effects, including but not limited to irritation, itch, inflammation, scaling, redness, rash, peeling, blistering

Trial Locations

Locations (1)

The Skin Center Dermatology Group

🇺🇸

New City, New York, United States

The Skin Center Dermatology Group
🇺🇸New City, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.